Werner Milton H.

Werner Milton H. is listed in filings as President and CEO at Inhibikase Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 22, 2025, including 15 public disclosures. Recent filings connect the profile to Inhibikase Therapeutics, Inc. (IKT). The current snapshot covers public activity from Jan 7, 2025 to Jan 22, 2025. Reported amounts are shown as $3.2M to $6.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.